|
EP1613774A2
(en)
|
2003-03-10 |
2006-01-11 |
Applera Corporation |
Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
|
|
JP2009523006A
(ja)
*
|
2004-05-07 |
2009-06-18 |
アプレラ コーポレイション |
脈管疾患に関連する遺伝的多型、その検出方法および使用
|
|
FI20041340A0
(fi)
*
|
2004-10-15 |
2004-10-15 |
Jurilab Ltd Oy |
Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi
|
|
US7747392B2
(en)
*
|
2004-12-14 |
2010-06-29 |
Genomas, Inc. |
Physiogenomic method for predicting clinical outcomes of treatments in patients
|
|
US20060278241A1
(en)
*
|
2004-12-14 |
2006-12-14 |
Gualberto Ruano |
Physiogenomic method for predicting clinical outcomes of treatments in patients
|
|
WO2007028147A2
(en)
*
|
2005-09-01 |
2007-03-08 |
Philadelphia Health & Education Corporation D.B.A. Drexel University College Of Medicin |
Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer
|
|
US7799530B2
(en)
*
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
|
DE102005048898A1
(de)
*
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
|
|
DE102005048899A1
(de)
*
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen
|
|
WO2007047634A2
(en)
*
|
2005-10-14 |
2007-04-26 |
The Regents Of The University Of California |
Method to diagnose, predict treatment response and develop treatments for psychiatric disorders using markers
|
|
US7838250B1
(en)
|
2006-04-04 |
2010-11-23 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of troponin
|
|
JP5308328B2
(ja)
|
2006-04-04 |
2013-10-09 |
シングレックス，インコーポレイテッド |
トロポニンの分析のための高感度のシステムおよび方法
|
|
WO2008005309A2
(en)
*
|
2006-06-30 |
2008-01-10 |
Dnaprint Genomics, Inc. |
Systems and methods for identifying and tracking individuals
|
|
US7651840B2
(en)
*
|
2006-07-14 |
2010-01-26 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
|
|
WO2008073201A2
(en)
*
|
2006-11-10 |
2008-06-19 |
Health Research Inc. |
Compositions and methods for identifying agents that alter expression of survivin
|
|
WO2008088836A2
(en)
*
|
2007-01-16 |
2008-07-24 |
The Burnham Institute For Medical Research |
Compositions and methods for treatment of colorectal cancer
|
|
WO2009021019A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Health Research Inc. |
Methods for analysis of pdef and survivin as interconnected cancer biomarkers and targets for personalized medicine
|
|
WO2009046395A2
(en)
*
|
2007-10-04 |
2009-04-09 |
The Regents Of The University Of California |
Method to predict response to treatment for psychiatric illnesses
|
|
US7947451B2
(en)
*
|
2007-11-30 |
2011-05-24 |
Celera Corporation |
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
|
BRPI1008532B1
(pt)
*
|
2009-02-12 |
2021-12-14 |
Janssen Biotech, Inc |
Arcabouço de proteína isolada, método para construção de uma biblioteca de arcabouço de proteína isolada, molécula de ácido nucleico isolada, vetor de ácido nucleico isolado, célula hospedeira de bactéria ou fungo, composição, dispositivo médico e artigo de manufatura para uso farmacêutico ou de diagnóstico em seres humanos
|
|
WO2010144358A1
(en)
|
2009-06-08 |
2010-12-16 |
Singulex, Inc. |
Highly sensitive biomarker panels
|
|
AU2011224534B2
(en)
*
|
2010-03-08 |
2014-10-09 |
Dana-Farber Cancer Institute, Inc. |
Full COLD-PCR enrichment with reference blocking sequence
|
|
CA2802971A1
(en)
*
|
2010-06-22 |
2011-12-29 |
Jjk Medical Ltd. |
New medium, devices and methods
|
|
US9072713B2
(en)
*
|
2010-07-01 |
2015-07-07 |
The Texas A&M University System |
Perlecan domain V protects, repairs and restores ischemic brain stroke injury and motor function
|
|
US11869024B2
(en)
*
|
2010-09-22 |
2024-01-09 |
The Nielsen Company (Us), Llc |
Methods and apparatus to analyze and adjust demographic information
|
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
|
WO2012112720A2
(en)
*
|
2011-02-15 |
2012-08-23 |
The Ohio University Research Foundaton |
Methods for predicting cardiovascular risks and responsiveness to statin therapy using snps
|
|
EP2691541B1
(en)
|
2011-03-31 |
2017-10-18 |
Dana-Farber Cancer Institute, Inc. |
Method for enriching in single-stranded mutant sequences from mixture of wild-type and mutant sequences
|
|
US8703425B2
(en)
*
|
2011-09-12 |
2014-04-22 |
The Chinese University Of Hong Kong |
Biomarker for gastric cancer
|
|
US9938576B1
(en)
|
2012-09-21 |
2018-04-10 |
Ohio State Innovation Foundation |
Materials and methods for determining metabolizer status in humans
|
|
US10913977B2
(en)
|
2013-07-24 |
2021-02-09 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to enable enrichment of minor DNA alleles by limiting denaturation time in PCR or simply enable enrichment of minor DNA alleles by limiting the denaturation time in PCR
|
|
WO2017165688A1
(en)
*
|
2016-03-23 |
2017-09-28 |
University Of Maryland, Baltimore |
Compositions and methods for genetically modifying myosin phosphatase target subunit (mypt1) gene for lowering blood pressure
|
|
WO2018111835A1
(en)
|
2016-12-12 |
2018-06-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for molecular barcoding of dna molecules prior to mutation enrichment and/or mutation detection
|
|
US11174511B2
(en)
|
2017-07-24 |
2021-11-16 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture
|
|
EP3434688A1
(en)
|
2017-07-24 |
2019-01-30 |
Commissariat à l'Energie Atomique et aux Energies Alternatives |
Hla-g transcripts and isoforms and their uses
|
|
MX2020010465A
(es)
|
2018-04-03 |
2021-01-08 |
|
Vectores de virus para direccionamiento a tejidos oftalmicos.
|
|
EP3774852A1
(en)
|
2018-04-03 |
2021-02-17 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
AU2019247748A1
(en)
|
2018-04-03 |
2020-10-08 |
Ginkgo Bioworks, Inc. |
Antibody-evading virus vectors
|
|
US20210093735A1
(en)
*
|
2018-04-26 |
2021-04-01 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treatment of hemophilia
|
|
MX2021008739A
(es)
*
|
2019-01-24 |
2021-10-13 |
Valorisation Hsj Lp |
Secuencias reguladoras de la transcripción específicas de células y usos de estas.
|
|
EP3935581A4
(en)
|
2019-03-04 |
2022-11-30 |
Iocurrents, Inc. |
DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
|
|
AR118465A1
(es)
|
2019-03-21 |
2021-10-06 |
Stridebio Inc |
Vectores de virus adenoasociados recombinantes
|
|
JP2022551739A
(ja)
|
2019-10-17 |
2022-12-13 |
ストライドバイオ，インコーポレイテッド |
ニーマン・ピック病ｃ型の治療のためのアデノ随伴ウイルスベクター
|
|
US12611436B2
(en)
|
2019-10-17 |
2026-04-28 |
Sarepta Therapeutics, Inc. |
AAV transfer cassette
|
|
AU2021328475A1
(en)
|
2020-08-19 |
2023-03-16 |
Sarepta Therapeutics, Inc. |
Adeno-associated virus vectors for treatment of Rett syndrome
|